• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Emergent BioSolutions

Emergent BioSolutions

  1. EBS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016

    EBS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016

  2. Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Those with Substantial Losses from Investment in Emergent BioSolutions , Inc. to Contact the Firm

    Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Those with Substantial Losses from Investment in Emergent BioSolutions , Inc. to Contact the Firm

  3. SHAREHOLDER ALERT: Holzer & Holzer Files Securities Class Action Lawsuit Against Emergent BioSolutions ; Reminds Investors of September 19, 2016 Deadline

    SHAREHOLDER ALERT: Holzer & Holzer Files Securities Class Action Lawsuit Against Emergent BioSolutions ; Reminds Investors of September 19, 2016 Deadline

  4. Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions , Inc. Investors and Encourages Investors to Contact the Firm

    Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions , Inc. Investors and Encourages Investors to Contact the Firm

  5. ABL Awarded Subcontract for the Production of an Inactivated Zika Virus Vaccine

    ABL Awarded Subcontract for the Production of an Inactivated Zika Virus Vaccine

  6. Aptevo Therapeutics Secures $35 Million Term Loan Agreement

    Aptevo Therapeutics Secures $35 Million Term Loan Agreement

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.